Table 3:
Unadjusted Relative risk ratio | 95% CI | p | Adjusted for age, site, and time in study Relative risk ratio | 95% CI | p | |||
---|---|---|---|---|---|---|---|---|
Outcome: Supportive male partner | ||||||||
Exposures: | ||||||||
Disclosure of ring use to primary partner | ||||||||
Yes | 1,534 | 1,202 (78.4) | 24.92 | 17.87-34.75 | <0.001 | 24.17 | 16.38-35.66 | <0.001 |
No/not sure | 408 | 92 (22.6) | Ref | Ref | ||||
Primary partner attended clinic to date | ||||||||
Yes | 276 | 224 (81.2) | 3.05 | 1.10-8.47 | 0.03 | 3.77 | 1.36-10.42 | 0.01 |
No | 1,666 | 1,070 (64.2) | Ref | Ref | ||||
Interaction: Disclosure x clinic attendance | 0.61 | 0.18-2.04 | 0.42 | 0.44 | 0.13-1.50 | 0.19 | ||
Outcome: Unsupportive male partner | ||||||||
Exposures: | ||||||||
Disclosure of ring use to primary partner | ||||||||
Yes | 1,534 | 227 (14.8) | 3.82 | 2.72-5.37 | <0.001 | 4.10 | 2.70-6.24 | <0.001 |
No/not sure | 408 | 112 (27.5) | Ref | Ref | ||||
Primary partner attended clinic to date | ||||||||
Yes | 276 | 34 (12.3) | 1.04 | 0.30-3.64 | 0.95 | 1.45 | 0.42-5.07 | 0.56 |
No | 1,666 | 305 (18.3) | Ref | Ref | ||||
Interaction: Disclosure x clinic attendance | 1.25 | 0.29-5.32 | 0.76 | 0.95 | 0.22-6.24 | 0.94 | ||
Outcome: Partner support unknown | Ref | Ref |
Study exit visits only. Excludes visits with missing data on partner support, product hold, or no primary partner reported.